Lyanne Harrison
Stock Analyst at Bank of America Securities
(0.73)
# 3,857
Out of 4,423 analysts
52
Total ratings
48.6%
Success rate
-5%
Average return
Main Sectors:
Stocks Rated by Lyanne Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RMD ResMed | Reiterated: Buy | $300 → $320 | $188.63 | +69.64% | 40 | Jun 4, 2026 | |
| ASX: ACL Australian Clinical Labs Limited | Upgraded: Buy | $3.60 | $2.19 | +64.38% | 1 | Jun 23, 2025 | |
| RCEL AVITA Medical | Maintained: Buy | n/a | $4.01 | n/a | 10 | Aug 9, 2024 | |
| ASX: SIG Sigma Healthcare Limited | Upgraded: Hold | $0.85 | $2.76 | n/a | 1 | Jun 7, 2023 |
ResMed
Jun 4, 2026
Reiterated: Buy
Price Target: $300 → $320
Current: $188.63
Upside: +69.64%
Australian Clinical Labs Limited
Jun 23, 2025
Upgraded: Buy
Price Target: $3.60
Current: $2.19
Upside: +64.38%
AVITA Medical
Aug 9, 2024
Maintained: Buy
Price Target: n/a
Current: $4.01
Upside: n/a
Sigma Healthcare Limited
Jun 7, 2023
Upgraded: Hold
Price Target: $0.85
Current: $2.76
Upside: n/a